Anti-inflammatory drug may shorten COVID-19 recovery time

Coronavirus

FILE – The Eli Lilly corporate headquarters is pictured April 26, 2017, in Indianapolis. A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalized COVID-19 patients shortens their time to recovery by an additional day. Eli Lilly announced the results Monday, Sept. 14, 2020, from a 1,000-person study sponsored by the U.S. National Institute of Allergy and Infectious Diseases. (AP Photo/Darron Cummings, File)

(AP) — A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalized COVID-19 patients shortens their time to recovery by an additional day. Eli Lilly announced the results Monday from a study of 1,000 people sponsored by the U.S. National Institute of Allergy and Infectious Diseases.

The results have not yet been published or reviewed by independent scientists. The study tested a pill that Indianapolis-based Lilly already sells to treat rheumatoid arthritis. All study participants received remdesivir, a drug previously shown to reduce the time to recovery by four days. Those who also were given the Lilly drug recovered one day sooner.

Stay with News 2 for continuing coverage of the COVID-19 Pandemic.

MORE COVERAGE

Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.



Don't Miss

Trending Stories